How Much Does Xeljanz Cost?
Xeljanz (Tofacitinib) costs an average of $1,685 per Medicare Part D claim, with total Medicare spending of $1456.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $1,685 |
| Total Medicare Spending | $1456.0M |
| Total Claims | 864,000 |
| Beneficiaries | 98,000 |
| Generic Available | Yes |
| Year-Over-Year Change | -8.9% |
Xeljanz (Tofacitinib) costs an average of $1,685 per Medicare Part D claim, with total Medicare spending of $1456.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.